(Q38263484)

1 September 2017

1 reference

title

Review of enterovirus 71 vaccines (English)

1 reference

1 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25352588%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Pele Chong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25352588%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Yen-Hung Chow

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25352588%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ai-Hsiang Chou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25352588%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Michel Klein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25352588%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

28 October 2014

1 reference

Clinical Infectious Diseases

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25352588%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25352588%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25352588%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

797-803

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25352588%20AND%20SRC:MED&resulttype=core&format=json

An overview of the evolution of enterovirus 71 and its clinical and public health significance

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Virology, epidemiology, pathogenesis, and control of enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Challenges to licensure of enterovirus 71 vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Enterovirus vaccines for an emerging cause of brain-stem encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Enterovirus 71: epidemiology, pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Progress on the research and development of human enterovirus 71 (EV71) vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Scavenger receptor B2 is a cellular receptor for enterovirus 71

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Update on the development of enterovirus 71 vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Hand foot and mouth disease due to enterovirus 71 in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Molecular epidemiology of enterovirus 71 strains isolated from children in Yamagata, Japan, between 1990 and 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Epidemiology of enterovirus 71 infections in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Hand, foot, and mouth disease in China, 2008-12: an epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Mutations in the non-structural protein region contribute to intra-genotypic evolution of enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

An inactivated enterovirus 71 vaccine in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Immunological and biochemical characterization of coxsackie virus A16 viral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Animal models of enterovirus 71 infection: applications and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Transgenic mouse model for the study of enterovirus 71 neuropathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852

Forecasting the economic value of an Enterovirus 71 (EV71) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU852